Abstract
Current concepts in the management of hepatic metastases have changed dramatically over the past two decades. Multidisciplinary therapies including chemotherapy, surgery, and regional therapy have alone and in combination significantly improved the survival of patients with metastatic colorectal cancer. Conditions that were previously considered hopeless and treated merely for palliation can now be approached with curative intent. In this paper, we review the surgical treatment for colorectal cancer liver metastasis (CRLM) and describe a paradigm-shift in the management of complex heretofore-considered unresectable CRLM. Utilizing advanced multidisciplinary treatment strategies has improved the prognosis of patients with stage IV colorectal cancer to the point where we may question whether CRLM are now a chronic disease.
Similar content being viewed by others
References
Siegel R et al (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62(4):220–41
Donadon M et al (2007) New paradigm in the management of liver-only metastases from colorectal cancer. Gastrointest Cancer Res 1(1):20–7
Abdalla EK et al (2006) Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13(10):1271–80
Baden H, Andersen B (1975) Survival of patients with untreated liver metastases from colorectal cancer. Scand J Gastroenterol 10(2):221–3
Bengtsson G et al (1981) Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 141(5):586–9
Gallagher DJ, Kemeny N (2010) Metastatic colorectal cancer: from improved survival to potential cure. Oncology 78(3–4):237–48
Charnsangavej C et al (2006) Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13(10):1261–8
Abdalla EK et al (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239(6):818–25, discussion 825–7
Choti MA et al (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235(6):759–66
Fong Y et al (1997) Liver resection for colorectal metastases. J Clin Oncol 15(3):938–46
Knoefel WT, Gabor I, Rehders A, Alexander A, Krausch M, Schulte am Esch J, Fürst G, Topp SA. (2012) In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection. Br J Surg 100(3):388–94
Narita M et al (2012) What is a safe future liver remnant size in patients undergoing major hepatectomy for colorectal liver metastases and treated by intensive preoperative chemotherapy? Ann Surg Oncol 19(8):2526–38
Scoggins CR et al (2009) Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases. Ann Surg Oncol 16(1):35–41
Zorzi D et al (2007) Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 94(3):274–86
Bipat S et al (2005) Colorectal liver metastases: CT, MR imaging, and PET for diagnosis–meta-analysis. Radiology 237(1):123–31
Fong Y et al (1999) Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg 178(4):282–7
Wiering B, Ruers TJ, Oyen WJ (2004) Role of FDG-PET in the diagnosis and treatment of colorectal liver metastases. Expert Rev Anticancer Ther 4(4):607–13
Wiering B et al (2008) Controversies in the management of colorectal liver metastases: role of PET and PET/CT. Dig Surg 25(6):413–20
Ekberg H et al (1986) Determinants of survival in liver resection for colorectal secondaries. Br J Surg 73(9):727–31
Pawlik TM, Schulick RD, Choti MA (2008) Expanding criteria for resectability of colorectal liver metastases. Oncologist 13(1):51–64
Yoo PS et al (2006) Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab. Clin Colorectal Cancer 6(3):202–7
Chua TC, Morris DL (2012) Resectable colorectal liver metastases: optimal sequencing of chemotherapy. J Gastrointest Cancer 43(3):496–8
Egger ME, Cannon RM, Metzger TL, Nowacki M, Kelly L, Tatum C, Scoggins CR, Callender GG, McMasters KM, Martin RC 2nd (2013) Assessment of chemotherapy response in colorectal liver metastases in patients undergoing hepatic resection and the correlation to pathologic residual viable tumor. J Am Coll Surg 216(4):845–56
Karoui M et al (2006) Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243(1):1–7
Nanji S et al (2013) Up-front Hepatic Resection for Metastatic Colorectal Cancer Results in Favorable Long-term Survival. Ann Surg Oncol 20(1):295–304
Parks R et al (2007) Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. J Am Coll Surg 204(5):753–61, discussion 761–3
Nordlinger B et al (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371(9617):1007–16
Adam R et al (2007) Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases. Surg Oncol Clin N Am 16(3):525–36, viii
Adam R et al (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240(4):644–57, discussion 657–8
Adam R et al (2000) Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg 232(6):777–85
Wicherts DA et al (2008) Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg 248(6):994–1005
Adam R et al (2001) Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 8(4):347–53
Benoist S, Nordlinger B (2009) The role of preoperative chemotherapy in patients with resectable colorectal liver metastases. Ann Surg Oncol 16(9):2385–90
Nordlinger B, Benoist S (2006) Benefits and risks of neoadjuvant therapy for liver metastases. J Clin Oncol 24(31):4954–5
Reddy SK et al (2012) Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases? J Surg Oncol 105(1):55–9
Venook AP (2003) Induction therapy in patients with metastatic colorectal cancer. Semin Oncol 30(4 Suppl 12):25–9
Covey AM et al (2008) Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg 247(3):451–5
Abulkhir A et al (2008) Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 247(1):49–57
Jaeck D et al (2004) A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 240(6):1037–49, discussion 1049–51
Vauthey JN, Zorzi D, Pawlik TM (2005) Making unresectable hepatic colorectal metastases resectable–does it work? Semin Oncol 32(6 Suppl 9):S118–22
Lalmahomed ZS et al (2011) Anatomical versus nonanatomical resection of colorectal liver metastases: is there a difference in surgical and oncological outcome? World J Surg 35(3):656–61
Kingham TP et al (2012) Patterns of recurrence after ablation of colorectal cancer liver metastases. Ann Surg Oncol 19(3):834–41
Nathan H et al (2010) Conditional survival after surgical resection of colorectal liver metastasis: an international multi-institutional analysis of 949 patients. J Am Coll Surg 210(5):755–64, 764–6
Inoue Y et al (2012) Resection margin with anatomic or nonanatomic hepatectomy for liver metastasis from colorectal cancer. J Gastrointest Surg 16(6):1171–80
Ayez N et al (2012) Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy. Ann Surg Oncol 19(5):1618–27
Dhir M et al (2011) Influence of margins on overall survival after hepatic resection for colorectal metastasis: a meta-analysis. Ann Surg 254(2):234–42
Nuzzo G et al (2008) Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: a single-center experience. Surgery 143(3):384–93
Zorzi D et al (2006) Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg 10(1):86–94
Pawlik TM et al (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241(5):715–22, discussion 722–4
Rees M, Plant G, Bygrave S (1997) Late results justify resection for multiple hepatic metastases from colorectal cancer. Br J Surg 84(8):1136–40
Stang A et al (2009) A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. Eur J Cancer 45(10):1748–56
Bale R et al (2012) Percutaneous stereotactic radiofrequency ablation of colorectal liver metastases. Eur Radiol 22(4):930–7
Lee KH et al (2012) Comparison of radiofrequency ablation and resection for hepatic metastasis from colorectal cancer. Korean J Gastroenterol 59(3):218–23
Kulaylat MN, Gibbs JF (2010) Thermoablation of colorectal liver metastasis. J Surg Oncol 101(8):699–705
Wu YZ et al (2011) Radiofrequency ablation vs hepatic resection for solitary colorectal liver metastasis: a meta-analysis. World J Gastroenterol 17(36):4143–8
Lorentzen T, Skjoldbye BO, Nolsoe CP (2011) Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients. Ultraschall Med 32(5):492–6
Ito K et al (2010) Surgical treatment of hepatic colorectal metastasis: evolving role in the setting of improving systemic therapies and ablative treatments in the 21st century. Cancer J 16(2):103–10
Giulianotti PC et al (2010) Minimally invasive sequential treatment of synchronous colorectal liver metastases by laparoscopic colectomy and robotic right hepatectomy. Int J Colorectal Dis 25(12):1507–11
Chua TC et al (2012) Hepatectomy and resection of concomitant extrahepatic disease for colorectal liver metastases–a systematic review. Eur J Cancer 48(12):1757–65
Elias D et al (2003) Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 90(5):567–74
Elias D et al (2004) Results of R0 resection for colorectal liver metastases associated with extrahepatic disease. Ann Surg Oncol 11(3):274–80
Pulitano C et al (2011) Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis. Ann Surg Oncol 18(5):1380–8
Chua TC et al (2012) Viewing metastatic colorectal cancer as a curable chronic disease. Am J Clin Oncol 35(1):77–80
Elias D et al (1998) Resection of liver metastases from colorectal cancer: the real impact of the surgical margin. Eur J Surg Oncol 24(3):174–9
Chua TC et al (2011) Predictors of cure after hepatic resection of colorectal liver metastases: an analysis of actual 5- and 10-year survivors. J Surg Oncol 103(8):796–800
Pulitano C et al (2010) What defines ‘cure’ after liver resection for colorectal metastases? Results after 10 years of follow-up. HPB (Oxford) 12(4):244–9
Tomlinson JS et al (2007) Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 25(29):4575–80
Ambiru S et al (1998) Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma. Cancer 82(2):274–8
Gonzalez M et al (2012) Survival after lung metastasectomy in colorectal cancer patients with previously resected liver metastases. World J Surg 36(2):386–91
Inoue M et al (2000) Surgery for pulmonary metastases from colorectal carcinoma. Ann Thorac Surg 70(2):380–3
Regnard JF et al (1998) Surgical treatment of hepatic and pulmonary metastases from colorectal cancers. Ann Thorac Surg 66(1):214–8, discussion 218–9
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guye, M.L., Schoellhammer, H.F., Chiu, L.W. et al. Designing Liver Resections and Pushing the Envelope with Resections for Hepatic Colorectal Metastases. Indian J Surg Oncol 4, 349–355 (2013). https://doi.org/10.1007/s13193-013-0256-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-013-0256-5